Boston BioLife is set to convene an exclusive, three-day Functional Longevity Medicine Summit from February 27 through March 1 in Phoenix, Arizona, gathering leading clinicians, scientists and health innovators to focus on the real-world future of precision-based care. The event, described as a working summit, aims to move beyond theory into actionable clinical and business strategies shaping the next era of preventive and personalized medicine.
With longevity medicine accelerating at an unprecedented pace, the summit will spotlight four critical pillars: the molecular science behind aging and cellular decline, advanced functional diagnostics guiding modern clinical decisions, breakthrough therapeutic strategies translating science into patient outcomes, and sustainable business models for longevity-focused medical practices. More than 100 forward-thinking medical and wellness professionals are expected to attend as they seek to stay ahead in one of healthcare's fastest-evolving sectors.
The summit features an impressive lineup of respected thought leaders, including Dr. Kien Vuu, physician and longevity expert; Bill Andrews, pioneering telomere researcher; Brian Bradley, performance strategist known for work with Tony Robbins; Patrick Porter, founder of BrainTap and neurotechnology innovator; and Amie Hornaman, thyroid and metabolic health specialist. Exhibitors will showcase cutting-edge technologies and therapeutics, including therapeutic plasma exchange programs from Lifespan Edge, alongside solutions from Life Armor, Pneuma Nitric Oxide, InHale and Integrative Peptides.
National and niche outlets including NDNR.com, the Next Generation Podcast Network, the Biohacking Index and Top Doctor Magazine are slated to cover the gathering, along with regional media. The event has also attracted former NFL player and entrepreneur AC Caswell, founder of Million Dollar Mingle Celebrity Charity Events. In partnership with Project One Cause, the summit will support charitable initiatives benefiting Scottsdale-area communities.
Joseph Krieger, founder and CEO of Boston BioLife, says, "This summit reflects a larger healthcare inflection point, as providers increasingly pivot from reactive treatment models toward proactive, data-driven longevity strategies." This shift from sick care to smart care is a central theme, underscoring the importance of the event as the field of longevity medicine evolves.
Clinicians and industry professionals interested in attending can learn more and secure tickets through BostonBioLife.com. The next event, the Spring Functional Longevity Summit, is tentatively set for June 4-7, 2026, in Washington D.C.
